February 27, 2025, at 8 to 9 PM ET to learn about a new subcutaneous prophylaxis option in a prefilled injection pen for adults and adolescents who have hemophilia B or A with inhibitors!
Our speaker, Dr Daisy Cortes, will discuss the new product’s clinical study, safety, efficacy, and mechanism of action. You’ll also learn about the innovative pen device! A Q&A session will follow the presentation to answer your questions. We hope you will join us!
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
